Analyst Ratings for Eli Lilly (lly)
lly Rating Summary
lly Price Target Summary
- Highest: $1,600.00 (Citi)
- Lowest: $940.00 (HSBC)
- Average: $1,326.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,326.92 (+12%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
Avg. $ Target:
$1,326.92 (+12%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2026 | Berenberg | Kerry Holford | Upgrade | Buy (Hold) |
1,400.00 (1,220.00) |
1115.70 (1184.63) |
6.18% | Details |
| 3/17/2026 | HSBC » Updated 9/10/2026 |
Rajesh Kumar | Downgrade | Reduce (Hold) |
940.00 (850.00) |
985.08 (1184.63) |
20.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
